James M Mock
CIK 1736359 · Chief Financial Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.56M
Companies
2
Total Filings
49
Lifetime Open-Market Net
-$3.60M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MRNA | Chief Financial Officer | 71,392 | $49.91 | $3.56M | -$1.04M | 34 | 2026-06-08 |
| REVVITY, INC. (PKI) Delisted | Please See Remarks | 30,530 | $115.24 | $3.52M | -$2.55M | 15 | 2022-06-27 |
Recent Filings · Page 2 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-06 | MRNA | Mixed | +750 | -$19.9K | EDGAR |
| 2025-08-29 | MRNA | Mixed | +568 | -$13.3K | EDGAR |
| 2025-07-07 | MRNA | Mixed | +750 | -$21.3K | EDGAR |
| 2025-05-29 | MRNA | Mixed | +568 | -$14.1K | EDGAR |
| 2025-04-07 | MRNA | Mixed | +749 | -$18.1K | EDGAR |
| 2025-03-03 | MRNA | Mixed | +169 | -$5.0K | EDGAR |
| 2025-02-28 | MRNA | Mixed | +2,966 | -$93.4K | EDGAR |
| 2025-01-06 | MRNA | Mixed | +673 | -$32.8K | EDGAR |
| 2024-12-06 | MRNA | Grant (A) | — | $0 | EDGAR |
| 2024-12-02 | MRNA | Mixed | +1,561 | -$60.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.